NASDAQ · NTRB
Nutriband Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for NTRB: Dec 9, 2026
Nutriband Inc. Common Stock is estimated to report earnings on 12/09/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.32.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks- RTTNews · Oct 8, 8:22 AM EDTNutriband Seeks New Patent Protection For AVERSA Transdermal Technology(RTTNews) – Nutriband Inc. (NTRB) announced that it has filed a non-provisional utility patent application with the U.S. Patent and Trademark Office to further strengthen intellectual property protection for its AVERSA abuse-deterrent transdermal technology.
- RTTNews · Dec 29, 11:25 AM ESTNutriband Stock Jumps 17% After Agreement To Sell 90% Of Pocono Pharma For $5 Mln(RTTNews) – Nutriband Inc. (NTRB) shares rose 17.29%, closing at $5.63, up $0.83, after the company announced an agreement to sell a 90% stake in its subsidiary Pocono Pharmaceutical to EarthVision Bio for $5 million in cash.
- RTTNews · Dec 29, 9:49 AM ESTNutriband To Sell A 90% Stake In Pocono Pharma For $5 Million To EarthVision Bio(RTTNews) – Nutriband Inc. (NTRB) Monday said it has agreed to sell a 90% stake in its subsidiary Pocono Pharmaceutical for $5 million to EarthVision Bio.
- Zacks · Nov 20, 8:10 AM ESTMediWound (MDWD) Reports Q3 Loss, Misses Revenue EstimatesMediWound (MDWD) delivered earnings and revenue surprises of +70.37% and -15.52%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Nov 13, 5:15 PM ESTTELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue EstimatesTELA Bio (TELA) delivered earnings and revenue surprises of -11.76% and -5.53%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Nov 12, 5:40 PM ESTKorro Bio, Inc. (KRRO) Reports Q3 Loss, Lags Revenue EstimatesKorro Bio, Inc. (KRRO) delivered earnings and revenue surprises of +26.44% and -27.33%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Nov 11, 5:10 PM ESTMetagenomi (MGX) Reports Q3 Loss, Lags Revenue EstimatesMetagenomi (MGX) delivered earnings and revenue surprises of +8.33% and -6.44%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Nov 10, 8:25 AM ESTIronwood Pharmaceuticals (IRWD) Q3 Earnings and Revenues Surpass EstimatesIronwood (IRWD) delivered earnings and revenue surprises of +166.67% and +78.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Oct 27, 7:43 AM EDTNutriband Co-Founder Gareth Sheridan Returns To The Role Of CEO(RTTNews) – Nutriband, Inc. (NTRB, NTRBW) announced Monday that Company Founder Gareth Sheridan has returned as Company Chief Executive Officer. Sheridan had stepped down from the role for three months to enter the Irish Presidential election.
- RTTNews · Oct 10, 1:38 AM EDTAfter-Hours Rally Lifts PALI, HCTI, NTRB, KPTI, EDIT, And CGON On Mixed News And Strategic Moves(RTTNews) – Several biotech stocks posted notable after-hours gains on Thursday, October 9, driven by fresh data, strategic updates, and corporate developments. Here's a quick look at the key movers and catalysts.
- Zacks · Sep 9, 6:45 PM EDTNutriband Inc. (NTRB) Reports Q2 Loss, Lags Revenue EstimatesNutriband (NTRB) delivered earnings and revenue surprises of -1,147.06% and -11.77%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 27, 6:20 PM EDTPhibro Animal Health (PAHC) Tops Q4 Earnings and Revenue EstimatesPhibro (PAHC) delivered earnings and revenue surprises of +9.62% and +4.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Nutriband Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.